Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
Oncologist 2021 Jan 19;[EPub Ahead of Print], JH Strickler, CN Rushing, HE Uronis, MA Morse, D Niedzwiecki, GC Blobe, AN Moyer, E Bolch, R Webb, S Haley, AJ Hatch, IP Altomare, GB Sherrill, DZ Chang, JL Wells, SD Hsu, J Jia, SY Zafar, AB Nixon, HI HurwitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.